- Investing.com
Metrics to compare | XBIT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipXBITPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.7x | −2.8x | −0.5x | |
PEG Ratio | 0.10 | −0.09 | 0.00 | |
Price/Book | 0.6x | 5.0x | 2.6x | |
Price / LTM Sales | - | 8.1x | 3.2x | |
Upside (Analyst Target) | - | 63.0% | 48.8% | |
Fair Value Upside | Unlock | −6.5% | 6.9% | Unlock |
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.